Literature DB >> 29053546

Histopathology of Calciphylaxis: Cohort Study With Clinical Correlations.

Tiffany Y Chen1, Julia S Lehman, Lawrence E Gibson, Christine M Lohse, Rokea A El-Azhary.   

Abstract

Calciphylaxis is a rare, painful, and life-threatening condition with a high mortality rate. Although the etiology of calciphylaxis is not well understood, it has been proposed that calcium deposition within and around subcutaneous vessels restricts blood flow chronically, thereby predisposing the patient to acute pannicular and dermal thrombosis. Given increasing recognition of the role of hypercoagulability in calciphylaxis, this retrospective cohort study sought to evaluate the presence of thromboses and dermal angioplasia in calciphylaxis. Moreover, we aimed to validate previous observations about the histopathology of calciphylaxis compared with skin biopsies from patients with end-stage renal disease but without calciphylaxis. After a meticulous clinical chart review, we assessed the corresponding skin biopsies for the presence of vessel calcification, thromboses, and dermal angioplasia in skin biopsies from patients with calciphylaxis (n = 57) and compared with those from patients with end-stage renal disease but without calciphylaxis (n = 26). Histopathologic findings were correlated with clinical features such as chronic kidney disease, diabetes, or associated malignancy. Our results validated a prior observation that calciphylaxis was significantly more likely to show calcification of dermal vessels and diffuse dermal thrombi. This study reports the frequent finding of dermal angioplasia, a potential marker of chronic low-grade ischemia, as another frequent microscopic finding in calciphylaxis. Among cases of calciphylaxis, histopathologic changes in patients with chronic kidney disease were indistinguishable from those in patients without chronic kidney disease, thereby implying a final common pathogenic pathway in both uremic and nonuremic calciphylaxis. In future, larger, prospective studies may be useful in validating these findings.

Entities:  

Mesh:

Year:  2017        PMID: 29053546     DOI: 10.1097/DAD.0000000000000824

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  13 in total

1.  Localization, Morphologic Features, and Chemical Composition of Calciphylaxis-Related Skin Deposits in Patients With Calcific Uremic Arteriolopathy.

Authors:  Hester Colboc; Philippe Moguelet; Dominique Bazin; Priscille Carvalho; Anne-Sophie Dillies; Guillaume Chaby; Hervé Maillard; Diane Kottler; Elisa Goujon; Christine Jurus; Marine Panaye; Vincent Frochot; Emmanuel Letavernier; Michel Daudon; Ivan Lucas; Raphaël Weil; Philippe Courville; Jean-Benoit Monfort; François Chasset; Patricia Senet
Journal:  JAMA Dermatol       Date:  2019-07-01       Impact factor: 10.282

2.  Use of the optimized sodium thiosulfate regimen for the treatment of calciphylaxis in Chinese patients.

Authors:  Xin Yang; Yuqiu Liu; Xiaotong Xie; Wen Shi; Jiyi Si; Xiaomin Li; Xiaoliang Zhang; Bicheng Liu
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

3.  Non-uraemic calciphylaxis (NUC) postliver transplantation.

Authors:  Simona Frunza-Stefan; Silpa Poola-Kella; Kristi Silver
Journal:  BMJ Case Rep       Date:  2018-10-24

4.  Nonuremic calciphylaxis in a COVID-19 patient.

Authors:  Natasha Mathur; Robert F Duffy; Brandyn Chinn; Miles M McFarland; Brian P Gable; Christina M Clay; Warren R Heymann
Journal:  Int J Dermatol       Date:  2021-05-17       Impact factor: 3.204

5.  Digital gangrene and pneumatosis intestinalis associated with calciphylaxis.

Authors:  Qingwen Kawaji; Erik Brian Eller; Jerry Yee; Judith C Lin
Journal:  J Vasc Surg Cases Innov Tech       Date:  2018-04-27

6.  Correlation between clinical and pathological features of cutaneous calciphylaxis.

Authors:  Puja Dutta; Kristine M Chaudet; Rosalynn M Nazarian; Daniela Kroshinsky; Sagar U Nigwekar
Journal:  PLoS One       Date:  2019-06-13       Impact factor: 3.240

7.  Gastrointestinal Manifestations in a Patient with Calciphylaxis: A Case Report.

Authors:  Shaun Jia Wei Kang; Krishan Madhan
Journal:  Case Rep Nephrol Dial       Date:  2019-08-28

8.  Calciphylaxis epidemiology, risk factors, treatment and survival among French chronic kidney disease patients: a case-control study.

Authors:  Raphaël Gaisne; Morgane Péré; Victorio Menoyo; Maryvonne Hourmant; David Larmet-Burgeot
Journal:  BMC Nephrol       Date:  2020-02-26       Impact factor: 2.388

9.  Non-uremic calciphylaxis associated with alcoholic hepatitis: A case report.

Authors:  Yasser M Sammour; Haitham M Saleh; Mohamed M Gad; Brayden Healey; Melissa Piliang
Journal:  World J Hepatol       Date:  2019-01-27

10.  Isolated Penile Calciphylaxis Diagnosed by Ultrasound Imaging in a New Dialysis Patient: A Case Report.

Authors:  Wryan Helmeczi; Tyler Pitre; Emma Hudson; Suhas Mondhe; Kevin Burns
Journal:  Can J Kidney Health Dis       Date:  2021-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.